BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Origin Agritech Announces Seed Product Pipeline and Biotechnology Trait Development Update

  Origin Agritech today released a progress update on growth platforms which are focused on the development and commercialization of superior corn seed products and high value biotechnology traits.

  December 18, 2017

   · 

  7 min read
• Drug Development

  Prometic’s Plasminogen (Ryplazim) Granted Orphan Drug Designation for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

  ProMetic announced today that an orphan drug designation status has been granted to its Plasminogen for the treatment of IPF by the FDA.

  December 18, 2017

   · 

  6 min read
• Transgene Announces Upcoming Investor Meetings in 2018

  Transgene will meet institutional investors from January 7 to 11, 2018, in San Francisco, USA, concurrent with the J.P. Morgan Healthcare conference.

  December 18, 2017

   · 

  1 min read
• 

  Business

  Sensorion and Cochlear Announce Collaboration to Study Combination Therapies for Cochlear Implant Patients

  The collaboration will evaluate therapeutic approaches using SENS-401 in combination with cochlear implants, with preclinical studies initiating in 2018, and potential clinical trials to begin as soon as 2019.

  December 18, 2017

   · 

  6 min read
• Pharm Country

  Madrigal Pharma Announces Proposed Public Offering of Common Stock

  Madrigal Pharma today announced that it has commenced an underwritten public offering of $100M of its common stock.

  December 18, 2017

   · 

  3 min read
• Drug Development

  RespireRx Pharma Publishes Compelling Scientific Evidence Demonstrating the Neurobiological Safety of Ampakine CX717 and Justifying Continued Clinical Development

  RespireRx, is pleased to announce that a paper detailing the neurobiologic safety of the ampakine CX717 has been accepted for publication by Toxicological Sciences, the Journal of the American Society of Toxicology.

  December 18, 2017

   · 

  8 min read
• Business

  Interpace Diagnostics Announces Agreement with ARUP Laboratories

  Interpace Diagnosticsi today announced that the Company has entered into a Laboratory Services Agreement with ARUP Laboratories, of Salt Lake City, Utah, whereby ARUP is utilizing Interpace Diagnostics as a laboratory services provider for its menu of molecular testing services.

  December 18, 2017

   · 

  6 min read
• FDA

  Biotricity Achieves FDA 510(k) Clearance for its Bioflux Device

  This latest 510(k) is the final FDA requirement needed for Biotricity to bring to market Bioflux in the US.

  December 18, 2017

   · 

  5 min read
• Business

  Horizon Discovery Enters Into Agreement With Roche Diagnostics to Support the Development of Immunohistochemistry Assays for Oncology

  Under the terms of the agreement, Horizon will develop and provide Reference Standard material expressing NTRK fusion biomarkers.

  December 18, 2017

   · 

  2 min read
• Immunovia Initiates the World’s Largest Study of New-Onset Diabetic Patients in a Prospective Pancreas Cancer Study Supported by Swelife

  Immunova AB today announced the initiation of PanDIA-1, the world’s largest prospective study of the new onset diabetes risk group for pancreatic cancer through a consortium with Lund and Uppsala Universities, Lund University Diabetes Center and Healthcare Region Skåne and Region Uppsala.

  December 18, 2017

   · 

  4 min read